Do sick newborn infants benefit from participation in a randomized clinical trial?
These data are consistent with the hypothesis that sick newborn infants may benefit from participation in a randomized controlled trial.
The incidence of renal dysfunction in low body weight patients treated with tenofovir was twice as high as those treated with abacavir. Close monitoring of renal function is recommended for patients with small body weight especially those with baseline body weight <60 kg treated with tenofovir.